Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies

  • Tagyedeen H. Shoaib
  • , Walaa Ibraheem
  • , Mohammed Abdelrahman
  • , Wadah Osman
  • , Asmaa E. Sherif
  • , Ahmed Ashour
  • , Sabrin R.M. Ibrahim
  • , Kholoud F. Ghazawi
  • , Samar F. Miski
  • , Sara A. Almadani
  • , Duaa Fahad ALsiyud
  • , Gamal A. Mohamed
  • , Abdulrahim A. Alzain

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Exploring the potential of approved drugs for triple-negative breast cancer treatment by targeting casein kinase 2: Insights from computational studies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science